David Baskin Md

This study tests a new approach for people with recurrent glioblastoma, an aggressive brain cancer. It combines gene therapy (HSV-tk) with an antiviral drug, radiation, and chemotherapy to try to control the disease. The goal is to see if this combination helps people live longer…